CD274 and neoplasm: PD-1 is an inhibitory receptor mainly expressed on activated T cells, B cells, macrophages, and dendritic cells, while PD-L1 is highly expressed by malignant tumour cells [15], as well as by tumour-infiltrating myeloid cells, including macrophages [16,17].